Atlas Trials

Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion

Clinical trial NCT01901692 · COMPLETED

Trial details

NCT number
NCT01901692
Sponsor
Asan Medical Center
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2013-07-29
Primary completion
2017-01-20
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.